Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers

Por Reyes, Henry D., Thiel, Kristina W., Carlson, Matthew J., Meng, Xiangbing, Yang, Shujie, Stephan, Jean- Marie, Leslie, Kimberly K.
Publicado em 2014

Placenta-Specific Protein 1: A Potential Key to Many Oncofetal-Placental OB/GYN Research Questions

Por Devor, Eric J., Reyes, Henry D., Santillan, Donna A., Santillan, Mark K., Onukwugha, Chinenye, Goodheart, Michael J., Leslie, Kimberly K.
Publicado em 2014

The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

Por Leslie, Kimberly K., Thiel, Kristina W., Reyes, Henry D., Yang, Shujie, Zhang, Yuping, Carlson, Matthew J., Kumar, Nirmala S., Dai, Donghai D.
Publicado em 2013

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182

Por DEVOR, ERIC J., SCHICKLING, BRANDON M., REYES, HENRY D., WARRIER, AKSHAYA, LINDSAY, BRITTANY, GOODHEART, MICHAEL J., SANTILLAN, DONNA A., LESLIE, KIMBERLY K.
Publicado no Oncol Rep (2016)

Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs

Por Meng, Xiangbing, Yang, Shujie, Zhang, Yuping, Wang, Xinjun, Goodfellow, Renee X., Jia, Yichen, Thiel, Kristina W., Reyes, Henry D., Yang, Baoli, Leslie, Kimberly K.
Publicado no J Biol Chem (2015)

Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices

Por Reyes, Henry D., Carlson, Matthew J., Devor, Eric J., Zhang, Yuping, Thiel, Kristina W., Samuelson, Megan I., McDonald, Megan, Yang, Shujie, Stephan, Jean-Marie, Savage, Erica C., Dai, Donghai, Goodheart, Michael J., Leslie, Kimberly K.
Publicado no Gynecol Oncol (2015)

Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer

Por Yang, Shujie, Jia, Yichen, Liu, Xiaoyue, Winters, Christopher, Wang, Xinjun, Zhang, Yuping, Devor, Eric J., Hovey, Adriann M., Reyes, Henry D., Xiao, Xue, Xu, Yang, Dai, Donghai, Meng, Xiangbing, Thiel, Kristina W., Domann, Frederick E., Leslie, Kimberly K.
Publicado no Oncotarget (2014)

Temsirolimus with or without Megestrol Acetate and Tamoxifen for Endometrial Cancer: a Gynecologic Oncology Group Study

Por Fleming, Gini F., Filiaci, Virginia L., Marzullo, Brandon, Zaino, Richard J., Davidson, Susan A., Pearl, Michael, Makker, Vicky, Burke, James J., Zweizig, Susan L., Van Le, Linda, Hanjani, Parviz, Downey, Gordon, Walker, Joan L., Reyes, Henry D., Leslie, Kimberly K.
Publicado em 2014

A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Por Bender, David, Sill, Michael W., Lankes, Heather A., Reyes, Henry D., Darus, Christopher J., Delmore, James E., Rotmensch, Jacob, Gray, Heidi J., Mannel, Robert S., Schilder, Jeanne M., Hunter, Mark I., McCourt, Carolyn K., Samuelson, Megan I., Leslie, Kimberly K.
Publicado no Gynecol Oncol (2015)